|
Volumn 33, Issue 1 SUPPL., 2004, Pages
|
First trimester down syndrome screening program using nuchal translucency and maternal serum markers: The Echo PAPP-A.78 study;Programme de dépistage de la trisomie 21 dans les Yvelines par mesure échographique de la clarté nucale et mesure des marqueurs sériques maternels au 1er trimestre de la grossesse: Étude Echo PAPP-A.78
|
Author keywords
Biochemical markers; Down syndrome; Screening; Ultrasound markers
|
Indexed keywords
CHORIONIC GONADOTROPIN BETA SUBUNIT;
PREGNANCY ASSOCIATED PLASMA PROTEIN A;
BIOLOGICAL MARKER;
CONFERENCE PAPER;
CONTROLLED STUDY;
DISEASE MARKER;
DOWN SYNDROME;
FETUS;
FETUS ECHOGRAPHY;
FIRST TRIMESTER PREGNANCY;
FRANCE;
HUMAN;
KARYOTYPE;
MAJOR CLINICAL STUDY;
MATERNAL AGE;
MATERNAL SERUM;
PRENATAL SCREENING;
REPRODUCIBILITY;
TRISOMY 21;
VALIDATION PROCESS;
ADULT;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
ECHOGRAPHY;
FEMALE;
MASS SCREENING;
METHODOLOGY;
MULTICENTER STUDY;
NECK;
PREGNANCY;
PRENATAL DEVELOPMENT;
PROSPECTIVE STUDY;
VALIDATION STUDY;
ADULT;
BIOLOGICAL MARKERS;
CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN;
DOWN SYNDROME;
FEMALE;
HUMANS;
MASS SCREENING;
NECK;
PREGNANCY;
PREGNANCY TRIMESTER, FIRST;
PREGNANCY-ASSOCIATED PLASMA PROTEIN-A;
PROSPECTIVE STUDIES;
REPRODUCIBILITY OF RESULTS;
ULTRASONOGRAPHY, PRENATAL;
|
EID: 0842268573
PISSN: 03682315
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (3)
|
References (0)
|